Waldencast (NASDAQ:WALD) Hits New 12-Month Low at $5.00

Waldencast plc (NASDAQ:WALDGet Free Report) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $5.00 and last traded at $5.00, with a volume of 1539 shares. The stock had previously closed at $5.07.

Analyst Upgrades and Downgrades

Separately, Telsey Advisory Group lowered their target price on shares of Waldencast from $10.00 to $8.00 and set an “outperform” rating on the stock in a research report on Wednesday.

View Our Latest Research Report on Waldencast

Waldencast Price Performance

The business has a fifty day simple moving average of $6.38 and a 200 day simple moving average of $8.15.

Institutional Investors Weigh In On Waldencast

A number of hedge funds and other institutional investors have recently bought and sold shares of WALD. Amalgamated Bank raised its stake in shares of Waldencast by 68.1% during the 3rd quarter. Amalgamated Bank now owns 3,277 shares of the company’s stock worth $31,000 after buying an additional 1,328 shares during the last quarter. Barclays PLC raised its stake in shares of Waldencast by 75.3% during the 3rd quarter. Barclays PLC now owns 7,177 shares of the company’s stock worth $67,000 after buying an additional 3,084 shares during the last quarter. Norden Group LLC acquired a new position in shares of Waldencast during the 1st quarter worth $92,000. State Board of Administration of Florida Retirement System acquired a new position in shares of Waldencast during the 3rd quarter worth $97,000. Finally, Simplicity Wealth LLC purchased a new stake in Waldencast during the 1st quarter worth about $142,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Waldencast Company Profile

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Read More

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.